Cite
HARVARD Citation
Andrews, L. et al. (2017). LAG3 (CD223) as a cancer immunotherapy target. Immunological reviews. 276 (1), pp. 80-96. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Andrews, L. et al. (2017). LAG3 (CD223) as a cancer immunotherapy target. Immunological reviews. 276 (1), pp. 80-96. [Online].